For citations:
Mayevskaya M.V., Bessonova Ye.N., Bogomolov P.O., Geyvandova N.I., Zhdanov K.V., Morozov V.G., Pasechnikov V.D., Khomenko I.Yu., Yagoda A.V., Ivashkin V.T. Pegilated interferon alpha 2b «Pegaltevir» chronic hepatitis C treatment (randomized clinical trial). Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2016;26(6):69-83. (In Russ.) https://doi.org/10.22416/1382-4376-2016-6-69-83